KaiPharm is an innovative pharmaceutical company based on Big Data, Bioinformatics, and A.I. Technology.
Genomics and other Omics is driving a comprehensive understanding of disease processes, and opened the age of precision medicine. Combination of AI technology & bio big data will accelerate drug discovery innovation and next generation pharmaceutical industry.
KaiPharm developed unique virtual screening methods by mining drug screening big data, and generated NGS-based full transcriptome data (KMAP) for thousands of drugs/compounds. We operate commercial service for drug-induced transcriptome (KMAP Express). A number of collaborative projects & services are performed with pharmaceutical companies, venture companies and research organizations regarding hit generation, drug’s MoA, indication discovery, drug repositioning, side effects, and disease subtype markers.
We will continue to be a reliable partner and solution provider by developing integrative solutions for innovative drug discovery and future medicine.
